Telitacicept in Primary APS Patients

Clinical trial NCT05078710 · TERMINATED

Trial details

NCT number: NCT05078710
Sponsor: Peking Union Medical College Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Anti Phospholipid Syndrome

Start date: 2021-07-01
Primary completion: 2022-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.